stockportfolio.pro
NewGenIvf Group Limited (NIVFW)
NasdaqCM
NewGenIvf Group Limited revenue & earnings — last 4 fiscal years
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | $5.94M | $5.14M | $5.43M | $4.73M |
| Gross profit | $1.54M | $1.68M | $1.83M | $955,846 |
| Net income | $458,667 | $130,193 | $-524,643 | $9.88M |
| Net margin | 7.7% | 2.5% | -9.7% | 209.0% |
Source: NewGenIvf Group Limited SEC filings (10-K).
Explore 4 years of NewGenIvf Group Limited financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a 7-day free trial to track NIVFW in your portfolio →
NewGenIvf Group Limited financial history by metric
About NewGenIvf Group Limited
NewGenIvf Group Limited, an investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan. The company provides a range of fertility treatment solutions, including in vitro fertilization (IVF), ICSI, embryo culture, hormonal blood tests, infectious diseases tests, chromosome screening, hysteroscopy, sperm analysis, sorting, washing, and freezing, and egg freezing. It also offers IVF treatment; surrogacy and ancillary caring services, and value-added services comprising nutrition guidance, psychological counselling, acupuncture, and translation interpreters to supplement the IVF treatment. The company provides its services through clinics. NewGenIvf Group Limited was founded in 2010 and is based in Bangkok, Thailand.
NewGenIvf Group Limited — frequently asked questions
What is NewGenIvf Group Limited's revenue?
NewGenIvf Group Limited (NIVFW) reported revenue of $4.73M for fiscal year 2025, down 13.0% from the prior year, according to its SEC filings.
Is NewGenIvf Group Limited profitable?
Yes. NIVFW earned net income of $9.88M in fiscal 2025, a net margin of 209.0%.
What is NIVFW's P/E ratio?
NewGenIvf Group Limited trades at a price-to-earnings ratio of about 0.0 based on the latest data in our nightly-refreshed cache.
How fast is NewGenIvf Group Limited growing?
NIVFW's revenue grew at roughly -7.4% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.
How much debt does NewGenIvf Group Limited have?
As of fiscal year 2025, NIVFW carried roughly $4.35M in total debt (short- plus long-term borrowings), per its filed balance sheet.
What is NewGenIvf Group Limited's gross margin?
NIVFW's gross margin was 20.2% in fiscal 2025 — gross profit of $955,846 on revenue of $4.73M.
What is NewGenIvf Group Limited's market cap?
NewGenIvf Group Limited (NIVFW) has a market capitalization of about $0, based on the latest data in our nightly-refreshed cache.
When does NewGenIvf Group Limited's fiscal year end?
NIVFW's fiscal year ends in December. Its most recent annual filing covers the fiscal year ending 2025-12-31.
Where does this data come from?
All figures are computed from NewGenIvf Group Limited's official SEC filings (10-K and 10-Q), covering 4 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.